Board of Directors

Richard C. Mulligan, Ph.D., joined our Board of Directors in 2009. Dr. Mulligan serves as Chair of our Science and Technology Committee and is a member of our Compensation and Management Development Committee. Dr. Mulligan is currently the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School, after serving as the Mallinckrodt Professor of Genetics and Director of the Harvard Gene Therapy Initiative from 1996 to 2013.  Dr. Mulligan is the Executive Vice Chairman of the Board of Sana Biotechnology, a private biotechnology company.  From March 2017 to October 2018, Dr. Mulligan served as a Portfolio Manager at Icahn Capital LP.  Prior to that, he was Professor of Molecular Biology at the Massachusetts Institute of Technology, a member of the Whitehead Institute for Biomedical Research and the Chief Scientific Officer of Somatix Therapy Corporation, a drug discovery and development company that he founded.  Dr. Mulligan was a founding partner of Sarissa Capital Management LP, a registered investment advisor, from 2013 to 2016. He was named a MacArthur Foundation Fellow in 1981.

Other Board of Directors Profiles